M Amylon
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation 9
- Acute Myeloid Leukemia Research 7
-
- Acute Lymphoblastic Leukemia research 13
-
- Childhood Cancer Survivors' Quality of Life 3
- Genetics top 10%
- Speech and Hearing top 5%
-
- Lymphoma Diagnosis and Treatment 4
-
- Polyomavirus and related diseases 3
- Neutropenia and Cancer Infections 3
-
- Cancer-related gene regulation 3
- Cited by
- HematologyPublic Health, Environmental and Occupational HealthPediatrics, Perinatology and Child Health
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
M Amylon
27 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Hematology 562
- Public Health, Environmental and Occupational Health 686
- Pediatrics, Perinatology and Child Health 346
- Genetics 121
- Speech and Hearing 69
Countries citing papers authored by M Amylon
This map shows the geographic impact of M Amylon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Amylon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Amylon more than expected).
Fields of papers citing papers by M Amylon
This network shows the impact of papers produced by M Amylon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Amylon. The network helps show where M Amylon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M Amylon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 1 | |
| 2 | 2000 | 20 | |
| 3 | 2000 | 55 | |
| 4 | 2000 | 29 | |
| 5 | 1999 | 95 | |
| 6 | 1998 | 41 | |
| 7 | 1998 | 4 | |
| 8 | 1997 | 58 | |
| 9 | Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. | 1997 | 35 |
| 10 | 1995 | 119 | |
| 11 | 1995 | 51 | |
| 12 | Bone marrow transplantation for thalassemia. The USA experience. | 1994 | 20 |
| 13 | 1993 | 95 | |
| 14 | 1993 | 75 | |
| 15 | Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia | 1992 | 28 |
| 16 | 1991 | 62 | |
| 17 | 1991 | 60 | |
| 18 | 1990 | 43 | |
| 19 | Probabilistic Prediction of the Outcome of Bone-Marrow Transplantation | 1989 | 5 |
| 20 | 1984 | 34 |
About M Amylon
M Amylon is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (13 papers), Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Polyomavirus and related diseases (3 papers), Neutropenia and Cancer Infections (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Hematology (562 citations), Public Health, Environmental and Occupational Health (686 citations) and Pediatrics, Perinatology and Child Health (346 citations). M Amylon has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Jeanette Pullen, JJ Shuster, Richard Baer, RG Smith, WM Crist, J J Shuster, S. Desai, S B Murphy, Joseph Laver and Bruce M. Camitta. Their work appears in journals such as Leukemia, Journal of Clinical Oncology, Blood, Radiology and The Journal of Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.